1.5899
-0.0201
(-1.25%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-707.0000
-901.0000
-1,049.0000
-850.0000
Investing Cash Flow
--
41.0000
36.0000
8.0000
32.0000
Financing Cash Flow
--
--
--
385.0000
--
End Cash Position
--
1,401.0000
2,094.0000
2,969.0000
3,631.0000
Capital Expenditure
--
--
--
--
-1.0000
Free Cash Flow
--
-707.0000
-901.0000
-1,049.0000
-851.0000
12/31/2020 - 9/1/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
GYX.F Futura Medical plc
0.1750
-50.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
PI3.DU Gubra AS
88.40
-0.23%
CVAC.VI CureVac N.V.
3.6780
-2.13%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4690
+1.52%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%
ORMP.TA Oramed Pharmaceuticals Inc.
796.60
-0.75%